News: Deals: Reports

Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Mutual Funds Taxes Ask the Expert Money 101 Autos Loan Center Best Places to Live Ask the Expert Millionaires in the Making Ultimate Guide to Retirement Retirement Calculators Best Funds Ask the Mole Best Places to Retire Personal Tech Big Tech Blog Techland Blog Sectors and Stocks Fortune 500 Techs Tech Talk 100 Best Places to Launch Ultimate Resource Guide Small Biz Makeovers FSB 100 Ask & Answer Fortune 500 Technology Investing Management Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts

Forbes Medi-Tech Inc- Pharmaceutical Assets & Business Unit & Transition Therapeutics Inc	Update Date: 09/25/08
Date Announced: 08/18/08
Value (million $USD): 7.0 million U.S. Dollar

Status: Completed

TRANSACTION DETAILS
Date Announced	08/18/08
Date Originally Announced	08/18/08
Format	Acq. of Assets	Acquisition techniques	Divestiture
Attitude	Friendly	Agency	n/a
Value	7.0 million U.S. Dollar	Advisor Fees	n/a

SYNOPSIS
US - Transition Therapeutics Inc acquired the pharmaceutical assets and business unit of Forbes Medi-Tech Inc, a provider of research and development services, for an estimated $7 mil. The consideration consisted of $1 mil in cash and up to $6 mil in profit related payments.

TARGET
Name	Forbes Medi-Tech Inc- Pharmaceutical Assets & Business Unit
Industries	Medicinal chemicals and botanical products; Biological products, except diagnostic substances
City	San Diego
State	CA
Nation	United States
Incorporated in	n/a
Public Status	Subsidiary
Business Description	The pharmaceuticals assets and business unit of Forbes Medi-Tech Inc manufactures pharmaceuticals.
Advisors	NULL
Target Sales	n/a

ACQUIROR
Name	Transition Therapeutics Inc (TSXVenture : TTH)
Industries	Medicinal chemicals and botanical products; Biological products, except diagnostic substances; Commercial physical and biological research
City	Toronto
State	n/a
Nation	Canada
Incorporated in	n/a
Public Status	Public
Business Description	Transition Therapeutics Inc, located in Toronto, Ontario, manufactures pharmaceuticals aimed at treating ailments such as diabetes, Alzheimer's disease, multiple sclerosis, and hepatitis C based on its ELND-005/AZD-103 small molecule therapeutic technology. The company was founded in 1998.
Advisors	NULL
Acquiror Sales	1.6 million U.S. Dollar 1.6 million Canadian Dollar

Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer

Copyright © 2008 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.